DUBLIN--(BUSINESS WIRE)--Dec 6, 2022--
The "Gene Therapy in Oncology Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The gene therapy in oncology market size was valued at US$2045 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 23.7% during 2022-2027. The gene therapy in oncology market report provides an executive-level overview of the gene therapy in oncology market worldwide today, with detailed forecasts of key indicators up to 2027.
This market intelligence report offers a thorough, forward-looking analysis of the global gene therapy in oncology market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.
The key to the growth has been the high prevalence of cancer and growing investment and funding for product development. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast period, the market will witness an increase in government initiatives, favoring the gene therapy in oncology market growth.
Scope
Reasons to Buy
Key Topics Covered:
CHAPTER 01 Executive Summary
CHAPTER 02 Research Scope and Segmentation
CHAPTER 03 Technology Briefing
CHAPTER 04 Gene Therapy in Oncology Industry Trends Analysis
CHAPTER 05 Global Gene Therapy in Oncology Revenue Opportunity
CHAPTER 06 Regulatory Overview
CHAPTER 07 Gene Therapy in Oncology Therapy Type Outlook
CHAPTER 08 Gene Therapy in Oncology End-User Outlook
CHAPTER 09 Gene Therapy in Oncology Regional Outlook
CHAPTER 010 Trends, Drivers, and Challenges
CHAPTER 011 Global Gene Therapy in Oncology Competitive Landscape
CHAPTER 012 Appendix
Companies Mentioned
Source: GlobalData
For more information about this report visit https://www.researchandmarkets.com/r/mdi4pu
View source version on businesswire.com:https://www.businesswire.com/news/home/20221206005774/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: GENETICS HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 12/06/2022 10:09 AM/DISC: 12/06/2022 10:09 AM
http://www.businesswire.com/news/home/20221206005774/en